George Douthit, MD
Adult Reconstructive Orthopaedic Surgery · Gadsden, ALNPI 1750307708
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (51.3%), education and food and beverage — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Arthrex at 51.3% of the total. Reporting peaked in 2019 at $3,661 and has fallen 95.0% since, to $185 in 2025.
Across 23 payments — averaging $254.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$3K
- Prime Surgical, LLC$2K
- Stryker$407
- Johnson & Johnson$274
- Orthofix Medical, Inc.$155
- Sanofi-aventis U.S. LLC$28
- plus $74 from 4 others
What the payments were for
- Speaking & faculty fees$3,00051%
- Travel & lodging$3997%
- Food & beverage$61110%
- Education$1,83531%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 1 | $3,000 |
| Prime Surgical, LLC | 3 | $1,906 |
| Stryker | 2 | $407 |
| Johnson & Johnson(2 entities) | 8 | $274 |
| Orthofix Medical, Inc. | 2 | $155 |
| Sanofi-aventis U.S. LLC | 2 | $28 |
| Boston Scientific | 2 | $27 |
| Bioventus LLC | 1 | $17 |
| Sanara Medtech Inc. | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INSPACE$399
- Spinal-Stim$145
How this compares
Too few adult reconstructive orthopaedic surgery providers in Alabamato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levofloxacin | 24 | $1,100 |
| Celecoxib | 17 | $991 |
| Cephalexin | 87 | $878 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 137 | $869 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 100 | $650 |
| Meloxicam | 133 | $546 |
| Rifampin | 12 | $330 |
| Hydroxyzine Pamoate | 39 | $134 |
| Dexamethasone | 39 | $97 |
| Tramadol Hcl | 34 | $90 |
| Amoxicillin | 41 | $47 |
| Cyclobenzaprine Hcl | 15 | $30 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Gadsden
- Christopher KelleyGadsden$234
- Matthew ClaytonHuntsville$51K
- Andrew McGeeDaphne$28K
- John MurphyAthens$9K
- Michael BlackmerFoley$5K
- Christopher ParksHuntsville$2K
- Todd SheilsOpelika$628
- William BoseMobile$563
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.